Skip to main content

Cryosurgical Ablation for Prostate Cancer

  • Chapter
New Technologies in Urology

Part of the book series: New Techniques in Surgery Series ((NEWTECHN,volume 7))

  • 853 Accesses

Prostate cancer is the most commonly diagnosed malignancy in the UK representing 24% of male cancers; the death rate from prostate cancer is significant at 3% of all male deaths.1 In many cases, the disease has a long period of asymptomatic growth before developing into locally advanced or metastatic disease with symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. UK CR. Prostate Cancer Incidence Statistics UK. London: Cancer Research; 2007

    Google Scholar 

  2. Ahmed S. A history of cryosurgery. In: Mattelaer JJ, ed. de Historia Urologiae Europaeae. Vol 13. Belgium: Historical Committee EAU; 2006:145–155

    Google Scholar 

  3. Arnott J. Practical illustrations of the remidial efficacy of very low or anaesthetic temperature. I. In Cancer. Lancet. 1850;2:257–259

    Article  Google Scholar 

  4. Cooper IS, Lee AS. Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis. 1961;133:259–263

    Article  CAS  PubMed  Google Scholar 

  5. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol. 1966;3(4):372–378

    CAS  PubMed  Google Scholar 

  6. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72(4):1291–1299

    Article  CAS  PubMed  Google Scholar 

  7. Lee F, Bahn DK, McHugh TA, Onik GM, Lee FT Jr. US-guided percutaneous cryoablation of prostate cancer. Radiology. 1994;192(3):769–776

    CAS  PubMed  Google Scholar 

  8. Cohen JK, Miller RJ, Shuman BA. Urethral warming catheter for use during cryoablation of the prostate. Urology. 1995;45(5):861–864

    Article  CAS  PubMed  Google Scholar 

  9. Larson TR, Rrobertson DW, Corica A, Bostwick DG. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology. 2000;55(4):547–552

    Article  CAS  PubMed  Google Scholar 

  10. Seifert JK, Gerharz CD, Mattes F, et al A pig model of hepatic cryotherapy. In vivo temperature distribution during freezing and histopathological changes. Cryobiology. 2003;47(3):214–226

    Article  PubMed  Google Scholar 

  11. Gage AA. History of cryosurgery. Semin Surg Oncol. 1998;14(2):99–109

    Article  CAS  PubMed  Google Scholar 

  12. Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann R Coll Surg Engl. 1984;66(5):313–318

    CAS  PubMed  Google Scholar 

  13. Baust JG, Gage AA. Progress toward optimization of cryosurgery. Technol.Cancer Res Treat. 2004;3(2):95–101

    CAS  PubMed  Google Scholar 

  14. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247(3 pt 1):125–142

    Google Scholar 

  15. Bischof JC, Smith D, Pazhayannur PV, Manivel C, Hulbert J, Roberts KP. Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level. Cryobiology. 1997;34(1):42–69

    Article  CAS  PubMed  Google Scholar 

  16. Hong JS, Rubinsky B. Patterns of ice formation in normal and malignant breast tissue. Cryobiology. 1994;42(1):59–68

    Google Scholar 

  17. Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48(3):441–447

    Article  CAS  PubMed  Google Scholar 

  18. Cooper IS. Cryobiology as viewed by the surgeon. Cryobiology. 1964;51:44–51

    Article  CAS  PubMed  Google Scholar 

  19. Dow JA, Waterhouse K. An experimental study in lethal freezing temperatures of the prostate gland. J Urol. 1970;103(4):454–457

    CAS  PubMed  Google Scholar 

  20. Klossner DP, Robilotto AT, Clarke DM, et al Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Cryobiology. 2007;55(3):189–199

    Article  PubMed  Google Scholar 

  21. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37(3):171–186

    Article  CAS  PubMed  Google Scholar 

  22. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int. 2005;95(9):1187–1191

    Article  PubMed  Google Scholar 

  23. Poppendiek HF, Randall R, Breeden JA, Chambers JE, Murphy JR. Thermal conductivity measurements and predictions for biological fluids and tissues. Cryobiology. 1967;3(4):318–327

    Article  Google Scholar 

  24. NICE. Interventional procedures overview of cryotherapy as a primary treatment for prostate cancer. London: National Institute of Clinical Excellence; 2005:1–15

    Google Scholar 

  25. Shelley M, Wilt TJ, Coles B, Mason MD. Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev. 2007;(3):CD005010

    Google Scholar 

  26. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS. Guideline for the management of clincially localised prostate cancer: 2007 update. J Urol. 2007;177:2106

    Article  PubMed  Google Scholar 

  27. Babaian RJ, Donnelly B, Bahn D, et al Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180(5):1993–2004

    Article  PubMed  Google Scholar 

  28. Chin JL, Ng CK, Touma NJ, et al Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis. 2008;11(1):40–45

    Article  CAS  PubMed  Google Scholar 

  29. Vicini FA, Kestin LL, Martinez AA. Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer. JAMA. 1999;281(17):1583–1584; discussion 1585–1586

    Article  CAS  PubMed  Google Scholar 

  30. Potters L, Klein EA, Kattan MW, et al Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol. 2004;71(1):29–33

    Article  PubMed  Google Scholar 

  31. D’Amico AV, Crook J, Beard CJ, DeWeese TL, Hurwitz M, Kaplan I. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell’s Urology. Philadelphia: Saunders; 2007:3014–3031

    Google Scholar 

  32. NICE. Prostate Cancer: Diagnosis and Treatment. Cardiff: Velindre NHS Trust, Cardiff, Wales; 2008

    Google Scholar 

  33. Thompson I, Thrasher JB, Aus G, et al Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106–2131

    Article  PubMed  Google Scholar 

  34. Partin AW, Kattan MW, Subong EN, et al Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277(18):1445–1451

    Article  CAS  PubMed  Google Scholar 

  35. Ghafar MA, Johnson CW, De La Taille A, et al Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001;166(4):1333–1337; discussion 1337–1338

    Article  CAS  PubMed  Google Scholar 

  36. Katz AE, Ghafar MA. Selection of salvage cryotherapy patients. Rev Urol. 2002;4(suppl 2):S18–S23

    PubMed  Google Scholar 

  37. Dudderidge T, Payne H, Emberton M. An algorithm for managing the failure of external beam radiotherapy in prostate cancer. BJU Int. 2007;100(3):518–527

    Article  CAS  PubMed  Google Scholar 

  38. Chan TY, Chan DY, Stutzman KL, Epstein JI. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol. 2001;166(6):2181–2184

    Article  CAS  PubMed  Google Scholar 

  39. Ahmed S, Lindsey B, Davies J. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy. Prostate Cancer Prostatic Dis. 2005;8(1):31–35.

    Article  CAS  PubMed  Google Scholar 

  40. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol. 2000;57(3):273–278

    Article  CAS  PubMed  Google Scholar 

  41. Cohen JK, Miller RJ Jr, Ahmed S, Lotz MJ, Baust J. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008;71(3):515–518

    Article  PubMed  Google Scholar 

  42. Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol. 2007;21(12):1521–1531

    Article  PubMed  Google Scholar 

  43. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001;57(3):518–523

    Article  CAS  PubMed  Google Scholar 

  44. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 suppl 1):3–11

    Article  PubMed  Google Scholar 

  45. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology. 2007;70(1):117–121

    Article  PubMed  Google Scholar 

  46. Donnelly BJ, Saliken JC, Ernst DS, et al Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60(4):645–649

    Article  CAS  PubMed  Google Scholar 

  47. El Hayek OR, Alfer W Jr, Reggio E, Pompeo AC, Arap S, Srougi M. Percutaneous prostate cryoablation as treatment for high-risk prostate cancer. Clinics. 2007;62(2):109–112

    Article  PubMed  Google Scholar 

  48. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103(8):1625–1630

    Article  PubMed  Google Scholar 

  49. Han KR, Cohen JK, Miller RJ, et al Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170(4 pt 1):1126–1130

    Article  PubMed  Google Scholar 

  50. Koppie TM, Shinohara K, Grossfeld GD, Presti JC Jr, Carroll PR. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol. 1999;162(2):427–432

    Article  CAS  PubMed  Google Scholar 

  51. Wong WS, Chinn DO, Chinn M, Chinn J, Tom WL. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79(5):963–974

    Article  CAS  PubMed  Google Scholar 

  52. Shinohara K, Connolly JA, Presti JC Jr, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996;156(1):115–120; discussion 120–121

    Article  CAS  PubMed  Google Scholar 

  53. Miller RJ Jr, Cohen JK, Merlotti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology. 1994;44(2):170–174

    Article  PubMed  Google Scholar 

  54. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001;165(6 pt 1):1937–1941; discussion 1941–1942

    CAS  PubMed  Google Scholar 

  55. de la Taille A, Hayek O, Benson MC, et al Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology. 2000;55(1):79–84

    Article  PubMed  Google Scholar 

  56. Bahn DK, Lee F, Silverman P, et al Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2(2):111–114

    PubMed  Google Scholar 

  57. Connolly JA, Shinohara K, Carroll PR. Cryosurgery for locally advanced (T3) prostate cancer. Semin Urol Oncol. 1997;15(4):244–249

    CAS  PubMed  Google Scholar 

  58. Pisters LL, von Eschenbach AC, Scott SM, et al The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997;157(3):921–925

    Article  CAS  PubMed  Google Scholar 

  59. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):559–563; discussion 563–564

    Article  PubMed  Google Scholar 

  60. Ng CK, Moussa M, Downey DB, Chin JL. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007;178(4 pt 1):1253–1257; discussion 1257

    Article  PubMed  Google Scholar 

  61. Bales GT, Williams MJ, Sinner M, Thisted RA, Chodak GW. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology. 1995;46(5):676–680

    Article  CAS  PubMed  Google Scholar 

  62. Pisters LL. Treatment failure after primary and salvage therapy for prostate cancer. Cancer. 2008;112(2):225–227

    Article  PubMed  Google Scholar 

  63. Gould RS. Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery. J Urol. 1999;162(5):1653–1657

    Article  CAS  PubMed  Google Scholar 

  64. Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007;100(4):760–764

    Article  PubMed  Google Scholar 

  65. Perrotte P, Litwin MS, McGuire EJ, Scott SM, von Eschenbach AC, Pisters LL. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol. 1999;162(2):398–402

    Article  CAS  PubMed  Google Scholar 

  66. Lam JS. Salvage cryosurgical ablation for radiorecurrent prostate cancer using third generation cryoneedles: the University of California-Los Angeles experience. J Urol. 2005;173:181

    Article  Google Scholar 

  67. Robinson JW, Donnelly BJ, Coupland K, et al Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Urol Oncol. 2006;24(6):472–486

    PubMed  Google Scholar 

  68. Onik G. Rationale for a “male lumpectomy,” a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol. 2008;31(1):98–106

    Article  PubMed  Google Scholar 

  69. Janzen NK, Han KR, Perry KT, Said JW, Schulam PG, Belldegrun AS. Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. J Endourol. 2005;19(4):520–525

    Article  PubMed  Google Scholar 

  70. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69(6):1117–1120

    Article  PubMed  Google Scholar 

  71. Romero-Mendez R, Franco W, Aguilar G. Laser-assisted cryosurgery of prostate: numerical study. Phys Med Biol. 2007;52(2):463–478

    Article  PubMed  Google Scholar 

  72. Cytron S, Paz A, Kravchick S, Shumalinski D, Moore J. Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas. Eur Urol. 2003;44(3):315–320; discussion 320–321

    Article  PubMed  Google Scholar 

  73. Jones JS. Ultrasound probe positioning to minimize the risk of recto-urethral fistula during cryosurgical ablation of prostate cancer. BJU Int. 2007;100(1):58–62; discussion 62

    Article  PubMed  Google Scholar 

  74. Clarke DM, Robilotto AT, VanBuskirk RG, Baust JG, Gage AA, Baust JM. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007;10(2):175–184

    Article  CAS  PubMed  Google Scholar 

  75. Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology. 2004;49(1):45–61

    Article  CAS  PubMed  Google Scholar 

  76. Goel R, Swanlund D, Coad J, Paciotti GF, Bischof JC. TNF-alpha-based accentuation in cryoinjury-dose, delivery, and response. Mol Cancer Ther. 2007;6(7):2039–2047

    Article  CAS  PubMed  Google Scholar 

  77. Gursel E, Roberts M, Veenema RJ. Regression of prostatic cancer following sequential cryotherapy to the prostate. J Urol. 1972;108(6):928–932

    CAS  PubMed  Google Scholar 

  78. Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol. 1970;104(1):154–159

    CAS  PubMed  Google Scholar 

  79. den Brok MH, Sutmuller RP, van der Voort R, et al In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 2004;64(11):4024–4029

    Article  Google Scholar 

  80. Joosten JJ, Muijen GN, Wobbes T, Ruers TJ. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology. 2001;42(1):49–58

    Article  CAS  PubMed  Google Scholar 

  81. Sabel MS, Nehs MA, Su G, Lowler KP, Ferrara JL, Chang AE. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat. 2005;90(1):97–104

    Article  CAS  PubMed  Google Scholar 

  82. Friedman EJ, Orth CR, Brewton KA, Ponniah S, Alexander RB. Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge. J Urol. 1997;158(4):1585–1588

    Article  CAS  PubMed  Google Scholar 

  83. Hoffmann NE, Coad JE, Huot CS, Swanlund DJ, Bischof JC. Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. Cryobiology. 2001;42(1):59–68

    Article  CAS  PubMed  Google Scholar 

  84. Hayakawa K, Yamashita T, Suzuki K, et al Comparative immunological studies in rats following cryosurgery and surgical excision of 3-methylcholanthrene-induced primary autochthonous tumors. Gann. 1982;73(3):462–469

    CAS  PubMed  Google Scholar 

  85. Moore FT, Blackwood J, Sazenbacher L, Pace WG. Cryotherapy for malignant tumors. Immunologic response. Arch Surg. 1968;96(4):527–529

    CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

Henderson, A., Ismail, M., Davies, J. (2010). Cryosurgical Ablation for Prostate Cancer. In: Dasgupta, P., Fitzpatrick, J., Kirby, R., Gill, I.S. (eds) New Technologies in Urology. New Techniques in Surgery Series, vol 7. Springer, London. https://doi.org/10.1007/978-1-84882-178-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-178-1_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-177-4

  • Online ISBN: 978-1-84882-178-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics